abrdn Life Sciences Investors (HQL)

CIK 884121 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for abrdn Life Sciences Investors.

Recent SEC filings

FiledFormAccession number
Aug 28, 2026NPORT-P0001410368-26-088530
Aug 21, 2026N-PX0001104659-26-099470
Jul 20, 202640001104659-26-085027
Jun 11, 202630001104659-26-072731
Jun 8, 2026N-CSRS0001104659-26-071379
May 29, 2026NPORT-P0001410368-26-056061
Apr 7, 2026DEF 14A0001104659-26-040392
Mar 6, 2026SCHEDULE 13G/A0001445546-26-001891
Feb 27, 2026NPORT-P0001410368-26-020666
Feb 23, 2026SCHEDULE 13D/A0001062993-26-001121
Feb 11, 2026SCHEDULE 13D/A0001062993-26-000816
Jan 8, 2026SCHEDULE 13D/A0001062993-26-000129
Dec 19, 202530001104659-25-123100
Dec 18, 202540001104659-25-122394
Dec 8, 2025N-CEN0001410368-25-033736
Dec 8, 2025N-CSR0001104659-25-119341
Nov 26, 2025NPORT-P0001410368-25-032525
Nov 24, 2025SCHEDULE 13D/A0001062993-25-016997
Sep 26, 2025SCHEDULE 13D/A0001062993-25-015817
Sep 23, 202540001510281-25-000498
Sep 19, 202540001510281-25-000492
Sep 17, 202540001510281-25-000488
Sep 15, 202540001510281-25-000481
Sep 4, 202540001510281-25-000449
Sep 3, 2025SCHEDULE 13D/A0001062993-25-015278